ICYMI: Results from a national survey of voters conducted by Fabrizio Ward, LLC show overwhelming bipartisan support for market-based solutions to lower Rx drug prices by holding #BigPharma accountable. See the results: https://lnkd.in/e8s695MK
The Campaign for Sustainable Rx Pricing (CSRxP)
非盈利组织
CSRxP is a coalition of leaders promoting bipartisan, market-based solutions to lower drug prices in America.
关于我们
To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.
- 网站
-
https://www.csrxp.org/
The Campaign for Sustainable Rx Pricing (CSRxP)的外部链接
- 所属行业
- 非盈利组织
- 规模
- 1 人
- 类型
- 非营利机构
动态
-
The results are in: A new survey conducted by Fabrizio Ward, LLC shows American voters overwhelmingly hold #BigPharma companies responsible for high Rx drug prices. Big Pharma must be held accountable with market-based solutions to lower prices. More ?? https://lnkd.in/eFmauKEg
-
-
The Campaign for Sustainable Rx Pricing (CSRxP)转发了
?? First Look: The The Campaign for Sustainable Rx Pricing (CSRxP) is launching a seven-figure ad campaign calling on Congress to act on #drug patent reform bills while pushing back on arguments from the pharmaceutical industry. Why it matters:?The post-recess advocacy aims to boost efforts to pass bipartisan patent overhauls this year in a bid to lower pharmaceutical prices. Driving the news:?One of the?first ads?in the TV and digital campaign calls for Congress to "get wise" to "patent games" from #pharmaceutical companies. Read the full story with analysis from Health Care Policy reporter Peter Sullivan on AxiosPro.com: https://lnkd.in/eGhH73Gu
-
??CSRxP launched a campaign to highlight #BigPharma’s egregious pricing practices and patent abuse that are the root cause of high drug prices — and encourage lawmakers to pass bipartisan, market-based solutions to hold Big Pharma accountable. More: https://lnkd.in/giYr6WgF
-
-
??MUST READ?? R Street Institute's Wayne Brough dives deep into #BigPharma’s patent abuse that keeps #RxDrug prices artificially high at the expense of patients and the U.S. healthcare system. Congress must crack down on Big Pharma’s anti-competitive practices: https://lnkd.in/geNwcPSZ
-
-
New research shows #BigPharma’s egregious pricing on GLP-1 diabetes and weight loss drugs and multimillion-dollar gene therapies are set to increase employers' health care costs next year. Read more: https://lnkd.in/evMBmycT
-
NEW: Eli Lilly and Company & Amgen posted blockbuster earnings after hiking prices on more than 40 #RxDrugs earlier this year. Surprised? Neither are we. Get the latest: https://lnkd.in/eRk3j8gr
-
-
Numerous price hikes = record breaking profits ?? #BigPharma giants reported expectation-beating Q2 earnings fueled by egregious pricing practices and anti-competitive tactics that block competition. Get the numbers: https://lnkd.in/epJZ6J_9
-
#BigPharma's ‘evergreening’ tactic extends monopolies and blocks affordable generics – and is yet another egregious abuse of the patent system. Thanks to Senators Dick Durbin and Bill Cassidy for reintroducing the bipartisan REMEDY Act to crack down on sham patents. Learn more: https://lnkd.in/ggv6n5m4
-
-
Are we surprised more brand name drug makers beat Wall Street earnings expectations? After repeated price hikes on their blockbuster products, #BigPharma pockets BILLIONS. Get the facts ?? https://lnkd.in/g6c5qk88
-